Newborn affected by maternal use of amphetamines

This code signifies a newborn experiencing adverse effects due to the mother's amphetamine use during pregnancy. These effects can manifest as neonatal abstinence syndrome (NAS) symptoms, neurodevelopmental issues, or other physiological disturbances directly attributable to in-utero exposure.

Apply this code when documentation clearly indicates a newborn's condition is a direct consequence of maternal amphetamine use. This includes cases where the infant exhibits withdrawal symptoms, feeding difficulties, or neurological signs linked to prenatal exposure. Supporting documentation should include maternal history of amphetamine use and a physician's assessment linking the newborn's symptoms to this exposure.

• Always sequence this code as a secondary diagnosis, following the code for the specific manifestation (e.g., neonatal withdrawal syndrome).
• Ensure documentation specifies "amphetamine" use; avoid using this code for other maternal substance use.
• Verify the physician's documentation explicitly states the newborn is "affected by" the maternal amphetamine use.